Barclays PLC Thermo Fisher Scientific Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Barclays PLC holds 1,521,471 shares of TMO stock, worth $906 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,521,471

Previous 17,800 8447.59%

Holding current value

$906 Million

Previous $9.45 Million 9259.61%

% of portfolio

0.31%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $6.24 Million - $7.08 Million	-11,803 Reduced 0.77%	1,521,471 $884 Million
Q4 2023 Feb 15, 2024	BUY	$431.41 - $532.94 $97.1 Million - $120 Million	225,176 Added 17.21%	1,533,274 $814 Million
Q3 2023 Nov 07, 2023	BUY	$498.29 - $574.41 $65 Million - $74.9 Million	130,394 Added 11.07%	1,308,098 $662 Million
Q2 2023 Aug 03, 2023	BUY	$508.46 - $591.13 $169 Million - $196 Million	331,790 Added 39.22%	1,177,704 $614 Million
Q1 2023 May 04, 2023	SELL	$535.0 - $604.82 $283 Million - $320 Million	-528,789 Reduced 38.47%	845,914 $488 Million

Q4 2022 Feb 13, 2023	BUY	$484.71 - $571.37 $168 Million - $197 Million	345,588 Added 33.58%	1,374,703 $757 Million
Q3 2022 Nov 03, 2022	BUY	$507.19 - $604.49 $23.4 Million - $27.8 Million	46,070 Added 4.69%	1,029,115 $522 Million
Q2 2022 Aug 12, 2022	SELL	$500.9 - $612.21 $20.9 Million - $25.5 Million	-41,717 Reduced 4.07%	983,045 $534 Million
Q1 2022 May 16, 2022	SELL	$524.0 - $644.92 $77.5 Million - $95.4 Million	-147,884 Reduced 12.61%	1,024,762 $605 Million
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $39.1 Million - $45.8 Million	68,711 Added 6.22%	1,172,646 $782 Million
Q3 2021 Nov 09, 2021	BUY	$509.53 - $609.78 $126 Million - $151 Million	246,875 Added 28.8%	1,103,935 $631 Million
Q2 2021 Aug 13, 2021	BUY	$441.0 - $508.24 $27.4 Million - $31.6 Million	62,084 Added 7.81%	857,060 $432 Million
Q1 2021 May 13, 2021	BUY	$439.85 - $518.83 $64.4 Million - $76 Million	146,403 Added 22.57%	794,976 $363 Million
Q4 2020 Feb 11, 2021	SELL	$435.06 - $527.66 $61.1 Million - $74.1 Million	-140,495 Reduced 17.81%	648,573 $302 Million
Q3 2020 Nov 12, 2020	BUY	$359.77 - $441.52 $202 Million - $248 Million	562,552 Added 248.35%	789,068 $348 Million
Q2 2020 Aug 12, 2020	SELL	$275.2 - $362.34 $46.2 Million - $60.8 Million	-167,875 Reduced 42.57%	226,516 $82.1 Million
Q1 2020 May 13, 2020	SELL	$255.3 - $340.05 $58 Million - $77.3 Million	-227,238 Reduced 36.56%	394,391 $112 Million
Q4 2019 Feb 10, 2020	BUY	$271.93 - $328.04 $16.4 Million - $19.8 Million	60,332 Added 10.75%	621,629 $202 Million
Q3 2019 Nov 14, 2019	SELL	$268.46 - $305.43 $28.5 Million - $32.4 Million	-106,035 Reduced 15.89%	561,297 $163 Million
Q2 2019 Aug 14, 2019	BUY	$257.51 - $295.55 $64 Million - $73.4 Million	248,387 Added 59.29%	667,332 $196 Million
Q1 2019 May 15, 2019	BUY	$212.17 - $273.72 $3.59 Million - $4.63 Million	16,910 Added 4.21%	418,945 $115 Million
Q4 2018 Feb 14, 2019	SELL	$208.47 - $251.98 $47.3 Million - $57.2 Million	-227,012 Reduced 36.09%	402,035 $90 Million
Q3 2018 Nov 14, 2018	SELL	$205.57 - $244.32 $27.7 Million - $32.9 Million	-134,537 Reduced 17.62%	629,047 $154 Million
Q2 2018 Aug 14, 2018	SELL	$203.14 - $219.53 $9.18 Million - $9.92 Million	-45,210 Reduced 5.59%	763,584 $158 Million
Q1 2018 May 15, 2018	SELL	$192.98 - $224.11 $58.4 Million - $67.8 Million	-302,462 Reduced 27.22%	808,794 $167 Million
Q4 2017 Feb 14, 2018	BUY	$182.03 - $200.37 $109 Million - $120 Million	600,015 Added 117.36%	1,111,256 $211 Million
Q3 2017 Nov 14, 2017	BUY	$171.74 - $194.04 $87.8 Million - $99.2 Million	511,241	511,241 $96.7 Million

Others Institutions Holding TMO

# of Institutions

2,721

Shares Held

331M

Call Options Held

1.58M

Put Options Held

2.01M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $233B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account